- Home
- TBPH vs CAL Comparison
TBPH vs CAL Comparison
Compare TBPH & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBPH
- CAL
- Stock Information
- Founded
- TBPH 2013
- CAL 1878
- Country
- TBPH United States
- CAL United States
- Employees
- TBPH N/A
- CAL N/A
- Industry
- TBPH Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- TBPH Health Care
- CAL Consumer Discretionary
- Exchange
- TBPH Nasdaq
- CAL Nasdaq
- Market Cap
- TBPH 536.5M
- CAL 520.3M
- IPO Year
- TBPH N/A
- CAL N/A
- Fundamental
- Price
- TBPH $11.15
- CAL $14.03
- Analyst Decision
- TBPH Strong Buy
- CAL Hold
- Analyst Count
- TBPH 5
- CAL 1
- Target Price
- TBPH $16.60
- CAL $14.00
- AVG Volume (30 Days)
- TBPH 245.1K
- CAL 1.0M
- Earning Date
- TBPH 08-04-2025
- CAL 05-29-2025
- Dividend Yield
- TBPH N/A
- CAL 2.00%
- EPS Growth
- TBPH N/A
- CAL N/A
- EPS
- TBPH N/A
- CAL 2.43
- Revenue
- TBPH $65,266,000.00
- CAL $2,677,706,000.00
- Revenue This Year
- TBPH $43.18
- CAL N/A
- Revenue Next Year
- TBPH N/A
- CAL $3.48
- P/E Ratio
- TBPH N/A
- CAL $5.78
- Revenue Growth
- TBPH 6.11
- CAL N/A
- 52 Week Low
- TBPH $7.44
- CAL $12.09
- 52 Week High
- TBPH $11.82
- CAL $44.51
- Technical
- Relative Strength Index (RSI)
- TBPH 62.38
- CAL 53.79
- Support Level
- TBPH $10.87
- CAL $12.14
- Resistance Level
- TBPH $11.44
- CAL $12.83
- Average True Range (ATR)
- TBPH 0.29
- CAL 0.70
- MACD
- TBPH -0.00
- CAL 0.22
- Stochastic Oscillator
- TBPH 71.92
- CAL 93.27
About TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.